Pure Global

Cortisol - India CDSCO Medical Device Registration

Cortisol is a medical device registered with India's Central Drugs Standard Control Organization (CDSCO) under UID IMP/IVD/2021/000365_a10038c486dfa8c5ab08e4681b4e8d7c_acaf63f252d9bb3e82064fe5623f6749. This device is marketed under the brand name AFIAS Infliximab . The license holder is BODITECH MED INDIA PRIVATE LIMITED, and it is classified as Device Class Class B. The approving authority is CDSCO.

This page provides comprehensive regulatory information including complete registration details, license holder information, device classification, and related products. Pure Global AI offers free access to 71,807+ India medical device registrations, helping global MedTech companies identify partners, analyze markets, and discover business opportunities efficiently.

Free Database
Powered by Pure Global AI
CDSCO Registered
Class Class B
Cortisol
UID: IMP/IVD/2021/000365_a10038c486dfa8c5ab08e4681b4e8d7c_acaf63f252d9bb3e82064fe5623f6749

Brand Name

AFIAS Infliximab

Device Class

Class B

Approving Authority

CDSCO

Product Information

AFIAS Cortisol is a fluorescence Immunoassay (AFIAS Infliximab ) for the quantitative determination of Cortisol in human whole blood/serum/plasma. It is useful as an aid in management and monitoring of concentration of cortisol

Pure Global
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing